China is a highly attractive clinical trial destination, and continues to see increased interest from CROs and drug development companies. China has a well-established tradition of developing medicines from basic research and the demands for modern pharmaceuticals is growing. Data gathered from clinicaltrials.gov indicated that in 2014, China had conducted 846 clinical trials, and an […]
了解更多
Chronic obstructive pulmonary disorder (COPD) is now the third most frequent cause of death in the world; however the cause of this disease for a substantial proportion of patients remains unknown.
了解更多
乔治临床( George Clinical ) in China would like to wish all of our clients, sponsors and investigators the best wishes for Lunar New Year. […]
了解更多
A diabetes epidemic is upon us, despite improved knowledge and therapy on this disease. The recently published 6th edition of the International Diabetes Federation Atlas provides some alarming figures.
了解更多
In order to meet the growing needs of our customers, 乔治临床( George Clinical ) has expanded its geographical footprint within Asia. In 2012 we saw the opening of a second 乔治临床( George Clinical ) […]
了解更多
乔治临床( George Clinical ) China has appointed a new General Manager to lead its growing operation in China as it seeks to provide a stronger platform for delivering clinical trials across the As […]
了解更多
